The reduction in the levels of chemokines CXCL1, CXCL2 and CXCL3 in melanoma results in a decrease in tumor angiogenesis and tumor growth, suggesting the importance of these chemokines in angiogenesis [59, 60]. This evidence concerns the gene CXCL1 and melanoma.